PHARMACOLOGICAL CONTROL OF BLOOD-COAGULATION BY SYNTHETIC, LOW-MOLECULAR-WEIGHT INHIBITORS OF CLOTTING ENZYMES - NEW CONCEPT OF ANTICOAGULANTS

被引：0
|
作者：
MARKWARDT, F
机构：
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 1980年 / 1卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：153 / 157
页数：5
相关论文
共 50 条
  • [31] Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems -: Comparison with heparin and low-molecular-weight heparin
    Olson, ST
    Swanson, R
    Raub-Segall, E
    Bedsted, J
    Sadri, M
    Petitou, M
    Hérault, JP
    Herbert, JM
    Björk, I
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (05) : 929 - 939
  • [32] INFLUENCE OF THE LOW-MOLECULAR WEIGHT HEPARIN FRAGMENT PK-10169 ON BLOOD-COAGULATION AND ON FIBRINOLYSIS INVITRO AND INVIVO
    VINAZZER, H
    WOLER, M
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 309 - 309
  • [33] ON THE ANTICOAGULANT ACTIONS OF APROSULATE SODIUM (LW 10082), A NEW SYNTHETIC LOW-MOLECULAR-WEIGHT POLYANION
    KLAUSER, RJ
    RAAKE, WD
    MEINETSBERGER, E
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1290 - 1290
  • [34] Testing of new anticancer therapeutics based on low-molecular-weight inhibitors of DNA-PK
    Pospisilova, Monika
    Seifrtova, Martina
    Andrs, Martin
    Korabecny, Jan
    Rezacova, Martina
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S29 - S29
  • [35] SIGNIFICANCE OF THROMBIN-RECEPTORS OF THROMBOCYTES FOR THE INTERACTION OF HEPARINS AND LOW-MOLECULAR-WEIGHT HEPARIN IN HUMAN WHOLE-BLOOD CLOTTING
    HARENBERG, J
    SCHULER, M
    ZIMMERMANN, R
    HEPTNER, W
    HAEMOSTASIS, 1988, 18 : 20 - 22
  • [36] PHARMACODYNAMIC EFFECTS ON BLOOD-COAGULATION OF A NEW LOW-MOLECULAR WEIGHT HEPARIN (ALFA-LMWH) IN HEALTHY-VOLUNTEERS AND GYNECOLOGICAL SURGERY PATIENTS
    PALARETI, G
    LEGNANI, C
    BIANCHINI, B
    GUAZZALOCA, G
    MACCAFERRI, M
    MARABINI, A
    DEIACO, P
    MARCOZZI, S
    MANCINI, L
    ORLANDI, C
    COCCHERI, S
    INTERNATIONAL ANGIOLOGY, 1989, 8 (01) : 47 - 52
  • [37] Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitors
    Calatzis, Andreas
    Peetz, Dirk
    Haas, Sylvia
    Spannagl, Michael
    Rudin, Karin
    Wilmer, Marianne
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (03) : 446 - 454
  • [38] CORRELATION OF THE ANTI-FACTOR-XA ACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN) AND THE ACTIVATED CLOTTING TIME OF WHOLE-BLOOD
    BRIEL, RC
    ZIELKE, E
    ZWIRNER, M
    ARZTLICHE LABORATORIUM, 1987, 33 (10): : 237 - 240
  • [39] Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs
    Thyes, Caroline
    Madjdpour, Caveh
    Frascarolo, Philippe
    Buclin, Thierry
    Buerki, Marco
    Fisch, Andreas
    Burmeister, Marc-Alexander
    Asmis, Lars
    Spahn, Donat R.
    ANESTHESIOLOGY, 2006, 105 (06) : 1228 - 1237
  • [40] ALTERATIONS OF BLOOD-COAGULATION AFTER SC AND IV APPLICATION OF LOW-MOLECULAR WEIGHT (LMW)-HEPARIN IN 105 PAT AND 40 NORMAL PERSONS
    KOSTERING, H
    MERTEN, HA
    GRAUDINS, J
    WUCHERPFENNIG, H
    BEHNKE, J
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 34 - 34
12345